Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED95 of ciprofol sedation with sufentanil
ChiCTR2500110957Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Oct 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in sedation and anesthesia induction (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: ED50 and ED95 of ciprofol with sufentanil at BIS ≤ 60. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
sedation and anesthesia induction
Beyond the preview
Go deeper on ChiCTR2500110957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110957.